Tom Scanlan, Ph.D., and Meredith D. Hartley, Ph.D.

Thyroid drug corrects metabolic defect in a rare genetic disorder

In 2017, research led by Tom Scanlan, Ph.D., professor of chemical physiology and biochemistry, OHSU School of Medicine, found that sobetirome, a synthetic thyroid drug developed in his lab years ago...

Scientists suggest new solution to the rare-disease problem

Better definition could lead to better diagnosis and treatment for rare diseases that cumulatively affect millions  Thousands of rare diseases cumulatively affect millions of people across the...

Luiz Bertassoni

Technology Transfer Innovation Spotlight: Luiz Bertassoni

Every year, approximately 4,000 new cases of bone or joint-related cancer are diagnosed in the United States. Treatment and recovery can be painful — often requiring surgical removal of the...

Couple at the flower market

Understanding multimorbidity to close the health disparity gap

Multimorbidity — having two or more coexisting chronic conditions — is highly prevalent, costly and disabling to older adults. Across racial and ethnic groups, multimorbidity affects older adults...

OHSU startup QuantiPort, Inc. has developed a system for measuring blood volume quickly and accurately.

OHSU startup spotlight: QuantiPort, Inc.

Trauma-related hemorrhage is a leading cause of death among adults under 45 years old, as well as children of all age groups. The diagnostic challenge is determining the volume of blood loss or...

Dopamine conducts special ensembles

A new study reports novel ways that dopamine cells influence the function of the prefrontal cortex of the brain.  Anyone who has savored a bite of chocolate or glanced at each new blinking...